$RGLS
Regulus Therapeutics Inc. Stock $rgls

$rgls Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-K Financial Statement

#000162828016011521 Filed on February 23, 2016

Income Statement

Concept	2016 Q1	2014 Q4	2014 Q3
Revenue	$489.0K	$4.219M	$1.083M
YoY Change	-88.36%	-22.64%	-82.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.100M	$3.280M	$2.570M
YoY Change	40.11%	74.47%	33.85%
% of Gross Profit
Research & Development	$16.76M	$10.47M	$10.17M
YoY Change	24.85%	27.22%	43.16%
% of Gross Profit
Depreciation & Amortization	$419.0K	$390.0K	$400.0K
YoY Change	6.35%	8.33%	8.11%
% of Gross Profit
Operating Expenses	$21.87M	$13.75M	$12.74M
YoY Change	28.09%	35.94%	41.22%
Operating Profit	-$21.38M		-$11.66M
YoY Change	66.09%		301.34%
Interest Expense	$24.00K	$100.0K	$10.00K
YoY Change	200.0%	42.86%	42.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$21.21M	-$22.17M	-$9.798M
YoY Change	46.38%	1036.92%	351.73%
Income Tax	-$5.000K	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$21.21M	-$22.17M	-$9.798M
YoY Change	46.39%	1050.39%	352.77%
Net Earnings / Revenue	-4336.81%	-525.43%	-904.71%
Basic Earnings Per Share	-$0.40	-$0.47	-$0.23
Diluted Earnings Per Share	-$4.831M	-$0.47	-$0.26
COMMON SHARES
Basic Shares Outstanding	52.70M shares	48.60M shares	43.41M shares
Diluted Shares Outstanding			44.86M shares

Balance Sheet

Concept	2016 Q1	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$105.1M	$159.7M	$94.10M
YoY Change	-29.37%	40.09%	-24.05%
Cash & Equivalents	$19.25M	$37.33M	$9.958M
Short-Term Investments	$85.80M	$122.4M	$84.10M
Other Short-Term Assets	$410.0K	$742.0K	$4.000M
YoY Change	-91.63%	-76.06%	207.69%
Inventory
Prepaid Expenses	$9.272M
Receivables	$100.0K	$300.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$115.8M	$165.0M	$98.02M
YoY Change	-26.97%	40.76%	-21.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.96M	$3.568M	$3.840M
YoY Change	218.12%	-5.31%	-3.54%
Goodwill
YoY Change
Intangibles	$1.069M	$1.150M	$1.114M
YoY Change	-1.66%	1.95%	-2.71%
Long-Term Investments
YoY Change
Other Assets	$354.0K	$1.811M	$1.038M
YoY Change	-80.33%	83.49%	483.15%
Total Long-Term Assets	$12.38M	$6.529M	$5.992M
YoY Change	95.53%	10.98%	12.97%
TOTAL ASSETS
Total Short-Term Assets	$115.8M	$165.0M	$98.02M
Total Long-Term Assets	$12.38M	$6.529M	$5.992M
Total Assets	$128.1M	$171.5M	$104.0M
YoY Change	-22.27%	39.34%	-20.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.622M	$2.188M	$2.642M
YoY Change	35.3%	86.69%	131.75%
Accrued Expenses	$5.456M	$4.402M	$3.633M
YoY Change	2.59%	46.1%	113.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$23.40M
YoY Change
Total Short-Term Liabilities	$11.01M	$35.19M	$11.89M
YoY Change	-23.27%	239.36%	-12.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$10.70M
YoY Change		-100.0%	-23.02%
Other Long-Term Liabilities	$7.850M	$1.022M	$1.142M
YoY Change	769.32%	-29.95%	-26.7%
Total Long-Term Liabilities	$7.850M	$1.022M	$1.142M
YoY Change	769.32%	-29.95%	-26.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.01M	$35.19M	$11.89M
Total Long-Term Liabilities	$7.850M	$1.022M	$1.142M
Total Liabilities	$20.91M	$39.47M	$29.94M
YoY Change	16.01%	33.3%	-17.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$212.7M	-$135.8M	-$113.6M
YoY Change	41.57%	71.67%	47.23%
Common Stock	$320.0M	$268.0M	$43.00K
YoY Change	7.67%	637942.86%	2.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$107.2M	$132.0M	$74.08M
YoY Change
Total Liabilities & Shareholders Equity	$128.1M	$171.5M	$104.0M
YoY Change	-22.27%	39.34%	-20.35%

Cashflow Statement

Concept	2016 Q1	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	-$21.21M	-$22.17M	-$9.798M
YoY Change	46.39%	1050.39%	352.77%
Depreciation, Depletion And Amortization	$419.0K	$390.0K	$400.0K
YoY Change	6.35%	8.33%	8.11%
Cash From Operating Activities	-$8.930M	-$11.66M	-$8.800M
YoY Change	-20.64%	25.24%	98.65%
INVESTING ACTIVITIES
Capital Expenditures	$395.0K	-$30.00K	-$390.0K
YoY Change	67.37%	-84.21%	14.71%
Acquisitions
YoY Change
Other Investing Activities	$12.09M	-$38.81M	$8.960M
YoY Change	-269.09%	529.01%	-132.99%
Cash From Investing Activities	$11.69M	-$38.84M	$8.580M
YoY Change	-258.2%	509.73%	-131.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$363.0K
YoY Change	41.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$528.0K	77.87M	160.0K
YoY Change	-42.3%	-778800.0%	-99.65%
NET CHANGE
Cash From Operating Activities	-$8.930M	-11.66M	-8.800M
Cash From Investing Activities	$11.69M	-38.84M	8.580M
Cash From Financing Activities	$528.0K	77.87M	160.0K
Net Change In Cash	$3.289M	27.37M	-60.00K
YoY Change	-118.55%	-274.44%	-100.42%
FREE CASH FLOW
Cash From Operating Activities	-$8.930M	-$11.66M	-$8.800M
Capital Expenditures	$395.0K	-$30.00K	-$390.0K
Free Cash Flow	-$9.325M	-$11.63M	-$8.410M
YoY Change	-18.83%	27.52%	105.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001505512
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52704783	shares
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013	rgls	Effective Income Tax Rate Reconciliation Reservefor Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationReserveforUncertainTaxPositionsAmount	0	USD
CY2014	rgls	Effective Income Tax Rate Reconciliation Reservefor Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationReserveforUncertainTaxPositionsAmount	0	USD
CY2015	rgls	Effective Income Tax Rate Reconciliation Reservefor Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationReserveforUncertainTaxPositionsAmount	254000	USD
CY2013	rgls	Income Tax Reconciliation Changein Fair Valueof Convertible Notes IncomeTaxReconciliationChangeinFairValueofConvertibleNotes	456000	USD
CY2014	rgls	Income Tax Reconciliation Changein Fair Valueof Convertible Notes IncomeTaxReconciliationChangeinFairValueofConvertibleNotes	4120000	USD
CY2015Q2	dei	Entity Public Float EntityPublicFloat	577700000	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	REGULUS THERAPEUTICS INC.
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Trading Symbol TradingSymbol	RGLS
CY2012Q4	rgls	Additional Tenant Improvement Allowance AdditionalTenantImprovementAllowance	700000	USD
CY2012Q4	rgls	Area Of Operating Lease AreaOfOperatingLease	7500	sqft
CY2015Q3	rgls	Area Of Operating Lease AreaOfOperatingLease	59000	sqft
CY2015Q4	rgls	Common Stock Voting Rights Votes CommonStockVotingRightsVotes	1	vote
CY2014Q4	rgls	Deferred Tax Assets Property Plant And Equipment And Intangible Assets DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets	1874000	USD
CY2015Q4	rgls	Deferred Tax Assets Property Plant And Equipment And Intangible Assets DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets	2097000	USD
CY2015	rgls	Defined Contribution Minimum Age Requirement Of Eligible Employees DefinedContributionMinimumAgeRequirementOfEligibleEmployees	P18Y
CY2015	rgls	Defined Contribution Plan Employee Contributions Percentageof Eligible Compensation DefinedContributionPlanEmployeeContributionsPercentageofEligibleCompensation	0.5
CY2015	rgls	Income Tax Reconciliation Changein Fair Valueof Convertible Notes IncomeTaxReconciliationChangeinFairValueofConvertibleNotes	616000	USD
CY2015Q3	rgls	Lease Term LeaseTerm	P96M
CY2010Q3	rgls	Mimimum Notice For Early Termination MimimumNoticeForEarlyTermination	P9M
CY2010Q3	rgls	Minimum Period For Early Termination MinimumPeriodForEarlyTermination	P60M
CY2015	rgls	Net Operating Loss Carryforward Limitation On Use Percentage Ownership Change Minimum NetOperatingLossCarryforwardLimitationOnUsePercentageOwnershipChangeMinimum	0.5
CY2013	rgls	Restricted Cash Tenant Improvement Allowance RestrictedCashTenantImprovementAllowance	0	USD
CY2014	rgls	Restricted Cash Tenant Improvement Allowance RestrictedCashTenantImprovementAllowance	0	USD
CY2015	rgls	Restricted Cash Tenant Improvement Allowance RestrictedCashTenantImprovementAllowance	1256000	USD
CY2015	rgls	Short Term Investment Maturity Weighted Average ShortTermInvestmentMaturityWeightedAverage	P2Y
CY2015Q4	rgls	Tenant Improvement Allowance TenantImprovementAllowance	1700000	USD
CY2012Q4	rgls	Tenant Improvement Allowance Interest Rate Percentage TenantImprovementAllowanceInterestRatePercentage	0.08
CY2013	rgls	Unrecognized Tax Benefits Increases Decreases Resultingfrom Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingfromPriorPeriodTaxPositions	137000	USD
CY2014	rgls	Unrecognized Tax Benefits Increases Decreases Resultingfrom Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingfromPriorPeriodTaxPositions	-73000	USD
CY2015	rgls	Unrecognized Tax Benefits Increases Decreases Resultingfrom Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingfromPriorPeriodTaxPositions	-250000	USD
CY2015Q4	rgls	Unrecognized Tax Benefitsthat Would Not Impact Effective Tax Rate UnrecognizedTaxBenefitsthatWouldNotImpactEffectiveTaxRate	1700000	USD
CY2014	rgls	Weighting Of Historical And Implied Volatility In Estimating Volatility Rate WeightingOfHistoricalAndImpliedVolatilityInEstimatingVolatilityRate	0.40
CY2014	rgls	Weighting Of Historical Volatility In Estimating Volatility Rate WeightingOfHistoricalVolatilityInEstimatingVolatilityRate	0.60
CY2014Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	274000	USD
CY2015Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	10021000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2188000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2717000	USD
CY2013	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1439000	USD
CY2014	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1597000	USD
CY2015	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1472000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4402000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6329000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5153000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6450000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-197000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-133000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	267929000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	164951000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	134258000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	315673000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3422000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7039000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15368000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	434000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	347000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3422000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7039000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15368000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5050929	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4027897	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1674119	shares
CY2014Q4	us-gaap	Assets Assets	171480000	USD
CY2015Q4	us-gaap	Assets Assets	141083000	USD
CY2014Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	159488000	USD
CY2015Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	113255000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	122416000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	98103000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	22000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	167000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	103000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	122580000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	98184000	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	76000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	223000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40552000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17807000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37327000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15960000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-22745000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	19520000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-21367000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	8893018	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48944530	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52669266	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48944530	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52669266	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	49000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	53000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18632000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-56861000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-55684000	USD
CY2014Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	23400000	USD
CY2014Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	23397000	USD
CY2015Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	USD
CY2015Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1356738	shares
CY2015Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	4.00
CY2015	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2015-10-09
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-20000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-17000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-19000	USD
CY2015Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	100000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	700000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	400000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3097000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1194000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3252000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2065000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1919000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1210000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	50095000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71984000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	48425000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	71641000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	200000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	8732000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	15148000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1999000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3488000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48425000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71641000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	34954000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	48912000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	617000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1129000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1670000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	343000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	USD
CY2015	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.25
CY2015	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1360000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1490000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1591000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.29
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.08
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2108000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2392000	USD
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12400000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M6D
CY2014	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0010
CY2014	us-gaap	Fair Value Assumptions Weighted Average Volatility Rate FairValueAssumptionsWeightedAverageVolatilityRate	1.10
CY2014	us-gaap	Fair Value Inputs Entity Credit Risk FairValueInputsEntityCreditRisk	0.097
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	296000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	379000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	100000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	100000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	100000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	100000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1446000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1460000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	100000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1150000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18691000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-56679000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1081000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-18000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-98000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7429000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11533000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19130000	USD
CY2015Q3	us-gaap	Incentive From Lessor IncentiveFromLessor	8500000	USD
CY2015Q3	us-gaap	Incentive From Lessor IncentiveFromLessor	1400000	USD
CY2014Q4	us-gaap	Incentive To Lessee IncentiveToLessee	600000	USD
CY2015Q4	us-gaap	Incentive To Lessee IncentiveToLessee	300000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55766000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-23000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9026000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20047000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	23216000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6355000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-19271000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-18960000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	667000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	902000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1161000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-86000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-50000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	204000	USD
CY2013	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-235000	USD
CY2014	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-92000	USD
CY2015	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	110000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1090000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2348000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1580000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2406000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3307000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	5039000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
CY2013	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	79000	USD
CY2014	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	196000	USD
CY2015	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	9746000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	860000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	940000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	529000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1355000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	556000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2094000	USD
CY2013	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-11000	USD
CY2014	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-282000	USD
CY2015	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-379000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-16819000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5039000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3090000	USD
CY2013	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-51000	USD
CY2014	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	811000	USD
CY2015	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	284000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	393000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	87000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	176000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1890000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1795000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3967000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1150000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1081000	USD
CY2013	us-gaap	Interest And Other Income InterestAndOtherIncome	292000	USD
CY2014	us-gaap	Interest And Other Income InterestAndOtherIncome	388000	USD
CY2015	us-gaap	Interest And Other Income InterestAndOtherIncome	855000	USD
CY2013	us-gaap	Interest Expense InterestExpense	36000	USD
CY2014	us-gaap	Interest Expense InterestExpense	39000	USD
CY2015	us-gaap	Interest Expense InterestExpense	52000	USD
CY2013	us-gaap	Interest Paid InterestPaid	37000	USD
CY2014	us-gaap	Interest Paid InterestPaid	39000	USD
CY2015	us-gaap	Interest Paid InterestPaid	27000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	600000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	39466000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	17005000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171480000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	141083000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35192000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12632000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	46474000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	88237000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7017000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40889000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29207000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21475000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28330000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39510000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-49859000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-18668000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-12741000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-11973000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-9798000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-22168000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-56680000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-14487000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-21035000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-13000000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-7226000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-55748000	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	11000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	42000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	28000	USD
CY2013	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-1145000	USD
CY2013	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-1100000	USD
CY2014	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-12118000	USD
CY2014	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-12100000	USD
CY2015	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-1800000	USD
CY2015	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-1811000	USD
CY2015	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segments
CY2013	us-gaap	Operating Expenses OperatingExpenses	37371000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	12336000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	13749000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	12742000	USD
CY2014Q4	us-gaap	Operating Expenses OperatingExpenses	13752000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	52579000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	17071000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	25015000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	15210000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	18221000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	75517000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-17802000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-44910000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-54758000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	21698000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1699000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2733000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2654000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2575000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2330000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9707000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	742000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	36000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-181000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	64000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1811000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	344000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	759000	USD
CY2014Q4	us-gaap	Revenues Revenues	4219000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1022000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2308000	USD
CY2013	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	653000	USD
CY2014	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	0	USD
CY2015	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	1656000	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	35000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	65000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	67000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	800000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1146000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1363000	USD
CY2013	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	72005000	USD
CY2014	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	113417000	USD
CY2015	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	78401000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4192000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8159000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	45980000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	86146000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	492000	USD
CY2013	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	31951000	USD
CY2014	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	85421000	USD
CY2015	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	101306000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	594000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2233000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2200000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6680000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8721000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11850000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3568000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5400000	USD
CY2013	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	100000	USD
CY2014	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	142000	USD
CY2015	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	155000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29942000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41046000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	56387000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1256000	USD
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1400000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135767000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191515000	USD
CY2013	us-gaap	Revenues Revenues	19569000	USD
CY2014Q1	us-gaap	Revenues Revenues	1631000	USD
CY2014Q2	us-gaap	Revenues Revenues	736000	USD
CY2014Q3	us-gaap	Revenues Revenues	1083000	USD
CY2014	us-gaap	Revenues Revenues	7669000	USD
CY2015Q1	us-gaap	Revenues Revenues	4200000	USD
CY2015Q2	us-gaap	Revenues Revenues	3834000	USD
CY2015Q3	us-gaap	Revenues Revenues	1865000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5700000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12100000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	21400000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1133000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.13
CY2015Q4	us-gaap	Revenues Revenues	10860000	USD
CY2015	us-gaap	Revenues Revenues	20759000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1915000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.14
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.37
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.47
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8461000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6643000	shares
CY2015	us-gaap	Severance Costs1 SeveranceCosts1	3900000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	3422000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	7039000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	15368000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1963000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.37
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5125667	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5126000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.95
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.91
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	8319000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4911000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	8.83
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.95
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.98
CY2015Q1	us-gaap	Share Price SharePrice	18.58
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5816000	USD
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M18D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M6D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y7M6D
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	122416000	USD
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	98103000	USD
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2299000	shares
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	201000	USD
CY2014	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	283000	USD
CY2015	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	492000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45779000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	76294000	USD
CY2015	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	25208000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	594000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2233000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6680000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	62093000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	93457000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	132014000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	124078000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	569000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1092000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1853000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2298000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	386000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	834000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	695000	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38479447	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	44090165	shares
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	51411353	shares
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk </font></div><div style="line-height:120%;padding-top:4px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash equivalents and short-term investments. We maintain deposits in federally insured financial institutions in excess of federally insured limits. We have not experienced any losses in such accounts and believe we are not exposed to significant risk. We maintain our cash equivalents and short-term investments with three financial institutions. We invest our excess cash primarily in commercial paper, certificates of deposit and debt instruments of financial institutions and corporations. Additionally, we adhere to established guidelines regarding approved investments and maturities of investments, which are designed to preserve their principal value and maintain liquidity.</font></div></div>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements and accompanying notes. An estimated loss contingency is accrued in our financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-16-011521-index-headers.html	Edgar Link	pending
0001628280-16-011521-index.html	Edgar Link	pending
0001628280-16-011521.txt	Edgar Link	pending
0001628280-16-011521-xbrl.zip	Edgar Link	pending
a10k-exx1010xemploymentagr.htm	Edgar Link	pending
a10k-exx1032xzurichlicagre.htm	Edgar Link	pending
a10k-exx231xconsentofindep.htm	Edgar Link	pending
a10k-exx311xcertificationo.htm	Edgar Link	pending
a10k-exx312xcertificationo.htm	Edgar Link	pending
a10k-exx321xcertificationp.htm	Edgar Link	pending
ex10322010zurichlicen_image1.gif	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
regcharta01.jpg	Edgar Link	pending
reguluschart.jpg	Edgar Link	pending
report.css	Edgar Link	pending
rgls-20151231.xml	Edgar Link	completed
rgls-20151231.xsd	Edgar Link	pending
rgls-20151231_cal.xml	Edgar Link	unprocessable
rgls-20151231_def.xml	Edgar Link	unprocessable
rgls-20151231_lab.xml	Edgar Link	unprocessable
rgls-20151231_pre.xml	Edgar Link	unprocessable
rgls20151231-10k.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGLS
Regulus Therapeutics Inc. Stock $rgls

2016 Q1 Form 10-K Financial Statement

#000162828016011521 Filed on February 23, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGLS Regulus Therapeutics Inc. Stock $rgls

2016 Q1 Form 10-K Financial Statement

#000162828016011521 Filed on February 23, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGLS
Regulus Therapeutics Inc. Stock $rgls